Cystic Fibrosis

Showing NaN - NaN of 110

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cystic Fibrosis Trial in United States (azithromycin, , Tobramycin solution for inhalation)

Completed
  • Cystic Fibrosis
  • Anchorage, Alaska
  • +44 more
Sep 12, 2019

Cystic Fibrosis Trial in Worldwide (CTX-4430, Placebo)

Completed
  • Cystic Fibrosis
  • Birmingham, Alabama
  • +74 more
Aug 22, 2019

Cystic Fibrosis Trial in Worldwide (PTI-428, Placebo)

Completed
  • Cystic Fibrosis
  • Stanford, California
  • +28 more
Mar 19, 2019

Cystic Fibrosis Trial in United States (Gallium nitrate, Normal Saline)

Completed
  • Cystic Fibrosis
  • Gallium nitrate
  • Normal Saline
  • Birmingham, Alabama
  • +22 more
Mar 20, 2019

Cystic Fibrosis Trial in Worldwide (QR-010, Placebo)

Completed
  • Cystic Fibrosis
  • Los Angeles, California
  • +26 more
Jan 15, 2019

The EPIC Observational Study

Completed
  • Cystic Fibrosis
    • Birmingham, Alabama
    • +53 more
    Jan 30, 2019

    Cystic Fibrosis, Motor Neuron Disease, Airway Clearance Impairment Trial in Chicago (MN 4000)

    Completed
    • Cystic Fibrosis
    • +2 more
    • MN 4000
    • Chicago, Illinois
      Northwestern
    Jan 7, 2019

    Cystic Fibrosis Trial in Canada, United States (LUM/IVA)

    Completed
    • Cystic Fibrosis
    • Palo Alto, California
    • +19 more
    Sep 30, 2018

    Cystic Fibrosis Trial in Chicago (Xylitol, Hypertonic saline)

    Completed
    • Cystic Fibrosis
    • Chicago, Illinois
    • +1 more
    Sep 28, 2018

    A Multi-Center Study of the CF Quantum® Sweat Test System

    Terminated
    • Cystic Fibrosis
    • Iontophoresis sweat test
    • Birmingham, Alabama
    • +5 more
    Aug 28, 2018

    Exocrine Pancreatic Insufficiency, Cystic Fibrosis Trial in Worldwide (Liprotamase, porcine (pig) PERT)

    Completed
    • Exocrine Pancreatic Insufficiency
    • Cystic Fibrosis
    • Long Beach, California
    • +53 more
    Jul 17, 2018

    Cystic Fibrosis Trial in Worldwide (VX-661 Plus Ivacaftor Combination, Ivacaftor, VX-661 Plus Ivacaftor Combination Placebo)

    Completed
    • Cystic Fibrosis
    • VX-661 Plus Ivacaftor Combination
    • +3 more
    • Little Rock, Arkansas
    • +74 more
    May 8, 2018

    Cystic Fibrosis Trial in Worldwide (VX-661 plus ivacaftor combination, Ivacaftor, Placebo (matched to VX-661 plus ivacaftor

    Completed
    • Cystic Fibrosis
    • VX-661 plus ivacaftor combination
    • +3 more
    • Birmingham, Alabama
    • +42 more
    May 8, 2018

    Cystic Fibrosis Trial in Worldwide (VX-661, Ivacaftor, Placebo matched to VX-661)

    Completed
    • Cystic Fibrosis
    • Birmingham, Alabama
    • +35 more
    Mar 14, 2018

    Cystic Fibrosis Trial in United States (VX-661, Ivacaftor, Placebo matched to VX-661)

    Completed
    • Cystic Fibrosis
    • Birmingham, Alabama
    • +22 more
    Mar 14, 2018

    Cystic Fibrosis Trial in Worldwide (MP-376 (Levofloxacin Solution for Inhalation), TIS (Tobramycin Inhalation Solution))

    Completed
    • Cystic Fibrosis
    • MP-376 (Levofloxacin Solution for Inhalation)
    • TIS (Tobramycin Inhalation Solution)
    • Mobile, Alabama
    • +129 more
    Jan 17, 2018

    Cystic Fibrosis Trial in Worldwide (MP-376 (Levofloxacin solution for Inhalation), Placebo)

    Completed
    • Cystic Fibrosis
    • MP-376 (Levofloxacin solution for Inhalation)
    • Placebo
    • Mobile, Alabama
    • +111 more
    Jan 17, 2018

    Cystic Fibrosis, Advanced Lung Disease Trial in United States (Lumacaftor, Ivacaftor)

    Completed
    • Cystic Fibrosis
    • Advanced Lung Disease
    • Denver, Colorado
    • +5 more
    Oct 31, 2017

    Cystic Fibrosis Trial in Worldwide (SB656933, Placebo)

    Completed
    • Cystic Fibrosis
    • Birmingham, Alabama
    • +32 more
    Oct 16, 2017

    Cystic Fibrosis Trial in Worldwide (VX-809, Placebo, VX-770)

    Completed
    • Cystic Fibrosis
    • Birmingham, Alabama
    • +53 more
    Sep 19, 2017

    Cystic Fibrosis Trial in United States (Dornase alfa, )

    Terminated
    • Cystic Fibrosis
    • Dornase alfa
    • placebo
    • Birmingham, Alabama
    • +39 more
    May 12, 2017

    Cystic Fibrosis Trial in Worldwide (Ivacaftor)

    Completed
    • Cystic Fibrosis
    • Birmingham, Alabama
    • +37 more
    Apr 3, 2017

    Cystic Fibrosis, Exocrine Pancreatic Insufficiency Trial in United States (EUR-1008 (APT-1008))

    Completed
    • Cystic Fibrosis
    • Exocrine Pancreatic Insufficiency
    • EUR-1008 (APT-1008)
    • Birmingham, Alabama
    • +13 more
    Feb 8, 2017

    Monitor Susceptibility to Aztreonam of Pseudomonas Aeruginosa

    Completed
    • Cystic Fibrosis
      • Anchorage, Alaska
      • +30 more
      Jan 9, 2017